This dysfunction leads to reduced ATP production and increased ROS formation, which results in oxidative stress and neuronal damage
Read More In a $2B deal, Novo licenses obesity drug from Chinas United Bio Building upon its already impressive obesity drug portfolio, Novo Nordisk A/S has licensed a triple agonist of the receptors for GLP-1, GIP and glucagon from United Biotechnology Co
We all deserve mental health support thats evidence-based, accessible, and affordable
Your clinician sets a starting dose and titration schedule based on tolerance, response, and goals never a one-size-fits-all protocol
When you're sleep-deprived, your hunger hormones are thrown out of whack
That pattern also explains why many professionals delay asking for help